Background: It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our aim was to describe the clinical course of AOM and the associated bacterial nasopharyngeal colonisation in a high-risk population of Australian Aboriginal children.Methods: We examined Aboriginal children younger than eight years who had a clinical diagnosis of AOM. Pneumatic otoscopy and video-otoscopy of the tympanic membrane (TM) and tympanometry was done every weekday if possible. We followed children for either two weeks (AOM without perforation), or three weeks (AOM with perforation), or for longer periods if the infection persisted. Nasopharyngeal swabs were taken at study entry and then weekly.Results: We enrolled 31 children and conduc...
Background The aim of this study was to assess the prevalence of hospitalisation for otitis media ac...
Background: Otitis media is a more frequent occurrence in children, and the disease may progress fro...
© 2006 Smith-Vaughan et al; licensee BioMed Central Ltd. This is an Open Access article distributed...
It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our aim was to des...
Abstract Background It is unclear why some children with acute otitis media (AOM) have poor outcomes...
© 2005 Morris et al; licensee BioMed Central Ltd. This is an Open Access article distributed under ...
Aboriginal children in remote Australia have high rates of complicated middle ear disease associated...
Background Aboriginal and Torres Strait Islander children experience a high burden of otitis media. ...
© 2008 Leach et al; licensee BioMed Central Ltd. This is an Open Access article distributed under t...
Background: Nasal colonisation with otitis media (OM) pathogens, particularly Streptococcus pneumoni...
© 2009 Mackenzie et al; licensee BioMed Central Ltd. This is an Open Access article distributed und...
Otitis media is endemic in remote Indigenous communities of Australia’s Northern Territory. Alloioco...
Australian Aboriginal children experience early, persistent and severe middle ear infections. We con...
BACKGROUND: Acute otitis media with perforation (AOMwiP) affects 40% of remote Indigenous children d...
Background: Despite a far from perfect correlation with middle ear growth, nasopharyngeal cultures a...
Background The aim of this study was to assess the prevalence of hospitalisation for otitis media ac...
Background: Otitis media is a more frequent occurrence in children, and the disease may progress fro...
© 2006 Smith-Vaughan et al; licensee BioMed Central Ltd. This is an Open Access article distributed...
It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our aim was to des...
Abstract Background It is unclear why some children with acute otitis media (AOM) have poor outcomes...
© 2005 Morris et al; licensee BioMed Central Ltd. This is an Open Access article distributed under ...
Aboriginal children in remote Australia have high rates of complicated middle ear disease associated...
Background Aboriginal and Torres Strait Islander children experience a high burden of otitis media. ...
© 2008 Leach et al; licensee BioMed Central Ltd. This is an Open Access article distributed under t...
Background: Nasal colonisation with otitis media (OM) pathogens, particularly Streptococcus pneumoni...
© 2009 Mackenzie et al; licensee BioMed Central Ltd. This is an Open Access article distributed und...
Otitis media is endemic in remote Indigenous communities of Australia’s Northern Territory. Alloioco...
Australian Aboriginal children experience early, persistent and severe middle ear infections. We con...
BACKGROUND: Acute otitis media with perforation (AOMwiP) affects 40% of remote Indigenous children d...
Background: Despite a far from perfect correlation with middle ear growth, nasopharyngeal cultures a...
Background The aim of this study was to assess the prevalence of hospitalisation for otitis media ac...
Background: Otitis media is a more frequent occurrence in children, and the disease may progress fro...
© 2006 Smith-Vaughan et al; licensee BioMed Central Ltd. This is an Open Access article distributed...